Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
Eli Lilly and Company
Boehringer Ingelheim
Institut Bergonié
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
Royal Marsden NHS Foundation Trust
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
National Cancer Institute (NCI)
Institut Bergonié
AIDS Malignancy Consortium
H. Lee Moffitt Cancer Center and Research Institute
Institut Bergonié
Abramson Cancer Center at Penn Medicine
National Taiwan University Hospital
Lytix Biopharma AS
Medical College of Wisconsin
Stanford University
Milton S. Hershey Medical Center
Guerbet
Quantum Surgical
Institut Bergonié
Institut Bergonié
Institut Bergonié
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Institut Bergonié
National Institutes of Health Clinical Center (CC)
Medical University of South Carolina
Emory University
Insel Gruppe AG, University Hospital Bern
Leap Therapeutics, Inc.
Eli Lilly and Company
Boehringer Ingelheim
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Institut Bergonié
Ipsen
Massachusetts General Hospital
M.D. Anderson Cancer Center
Institut Bergonié
Ohio State University
Columbia University
Masonic Cancer Center, University of Minnesota
ImmunoGenesis
Thomas Jefferson University
Vanderbilt-Ingram Cancer Center